Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1846403rdf:typepubmed:Citationlld:pubmed
pubmed-article:1846403lifeskim:mentionsumls-concept:C0007765lld:lifeskim
pubmed-article:1846403lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:1846403lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:1846403lifeskim:mentionsumls-concept:C0205812lld:lifeskim
pubmed-article:1846403pubmed:issue2lld:pubmed
pubmed-article:1846403pubmed:dateCreated1991-2-26lld:pubmed
pubmed-article:1846403pubmed:abstractText[3H]Kainate bound to chick cerebellar membranes with a KD of 0.6 microM and with an exceptionally high Bmax of 165 pmol/mg of protein. In octylglucoside-solubilised extracts, the affinity of [3H]kainate was reduced (KD = 2.7 microM), but the Bmax was relatively unchanged (130 pmol/mg of protein). The rank potency of competitive ligands was domoate greater than kainate greater than 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) greater than glutamate. Binding sites for alpha-[3H]amino-3- hydroxy-5-methylisoxazolepropionate ([3H]AMPA) were much less abundant, with KD and Bmax values in membranes of 86 nM and 1 pmol/mg of protein, respectively. The affinity of [3H]AMPA binding was also reduced on solubilisation (KD = 465 nM), but there was an increase in the Bmax (1.7 pmol/mg of protein). Quisqualate and CNQX were the most effective displacers of [3H]AMPA binding, but kainate was also a relatively potent inhibitor. However, in contrast to the displacement profile for [3H]kainate, domoate was markedly less potent than kainate at displacing [3H]AMPA. These results suggest that [3H]AMPA binds to a small subset of the kainate sites that, unlike the majority of the [3H]kainate binding protein, which has been reported to be located in the Bergmann glia, may represent neuronal unitary non-N-methyl-D-aspartate receptors.lld:pubmed
pubmed-article:1846403pubmed:languageenglld:pubmed
pubmed-article:1846403pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:citationSubsetIMlld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846403pubmed:statusMEDLINElld:pubmed
pubmed-article:1846403pubmed:monthFeblld:pubmed
pubmed-article:1846403pubmed:issn0022-3042lld:pubmed
pubmed-article:1846403pubmed:authorpubmed-author:BarnardE AEAlld:pubmed
pubmed-article:1846403pubmed:authorpubmed-author:HenleyJ MJMlld:pubmed
pubmed-article:1846403pubmed:issnTypePrintlld:pubmed
pubmed-article:1846403pubmed:volume56lld:pubmed
pubmed-article:1846403pubmed:ownerNLMlld:pubmed
pubmed-article:1846403pubmed:authorsCompleteYlld:pubmed
pubmed-article:1846403pubmed:pagination702-5lld:pubmed
pubmed-article:1846403pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:meshHeadingpubmed-meshheading:1846403-...lld:pubmed
pubmed-article:1846403pubmed:year1991lld:pubmed
pubmed-article:1846403pubmed:articleTitleComparison of solubilised kainate and alpha-amino-3-hydroxy-5- methylisoxazolepropionate binding sites in chick cerebellum.lld:pubmed
pubmed-article:1846403pubmed:affiliationMolecular Neurobiology Unit, MRC Centre, Cambridge, England.lld:pubmed
pubmed-article:1846403pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1846403pubmed:publicationTypeComparative Studylld:pubmed